Form4insider filings, from the source

SEC Form 4 · accession 0001562180-18-005027

ARRAY BIOPHARMA INC · ARRY

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Ron Squarer
Officer — CEO · Director
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 7:48 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100412

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 16, 2018M48,437$0.00A260,012D
Common StockF2Dec 16, 2018F21,303$15.97D238,709D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF3$0.00Dec 14, 2018A113,125A—Dec 20, 2022Common Stock113,125113,125D
Stock Option (Right to Buy)F4$0.00Dec 14, 2018A678,750A—Dec 16, 2028Common Stock678,750678,750D
Restricted Stock UnitsF5$0.00Dec 16, 2018M23,437D—Dec 16, 2020Common Stock23,43746,876D
Restricted Stock UnitsF5$0.00Dec 16, 2018M25,000D—Dec 17, 2021Common Stock25,00075,000D

Explanation of responses